Subscribe to Biological Therapies in Psychiatry -  Choose your plan >
IN THIS MONTH'S ISSUE:
May 2017

Over-the-Counter Melatonin: Purity and Composition
Widely used in the United States to treat insomnia, although banned in many other countries, over-the-counter melatonin products exhibit extreme discrepancies in actual versus labeled content.

DBS for OCD
Preliminary results from a small pilot study suggest that deep brain stimulation (DBS) might be considered for patients with obsessive-compulsive disorder (OCD) who are incompletely responsive to medication and cognitive behavioral therapy (CBT).

Vitamin D Levels in Psychiatric Disorders
Two studies report that patients with psychiatric illnesses have a higher incidence of vitamin D deficiency than the general population.

In Brief
Long-Term Treatment with ADHD Medication Associated with Decreased Height and No Reduction of Symptom Severity in Adults; Treatment with Antioxidant Supplements Does Not Appear to Prevent Dementia

Infections, Antibiotics, and Mental Illness
Anti-infective agents, particularly broad-spectrum antibiotics, may be associated with an increased risk of developing schizophrenia or affective disorders.

Exercise and Depression in Children
A study in children suggests moderate-to-vigorous exercise at ages 6 and 8 years may prevent future symptoms of major depressive disorder.

About the BTP Newsletter

Our subscribers say BTP is…

"Very relevant, practical, and thought-provoking."

"About the only thing left without drug ads...objective and balanced."

"Succinct, readable, clear, timely and relevant!"

"Well written and scientifically sound."

Originating at the Massachusetts General Hospital and Harvard Medical School, Biological Therapies in Psychiatry has been a trusted resource for physicians for over 30 years. Described as "influential" by the Atlantic Monthly, this concise, four-page, monthly newsletter provides up-to-date information about the rapidly expanding field of psychotropic medications and other biological treatments for mental disorders.

From his perspective as an editor, teacher, investigator, and clinician, Alan J. Gelenberg, M.D., reviews the widespread literatures of science and clinical practice. Dr. Gelenberg distills the material most relevant for a busy practitioner and presents it each month with a balance of scientific curiosity, healthy skepticism, and clinical experience.

Dr. Gelenberg is Professor and Interim Chair of Psychiatry at Penn State, Hershey. Since 1987, Dr. Gelenberg has been Editor-in-Chief of the Journal of Clinical Psychiatry, and he recently chaired the workgroup that revised the American Psychiatric Association's major depressive disorder guidelines. Dr. Gelenberg has been on the faculty of Harvard Medical School, MIT, and the University of Arizona and has written numerous scientific articles and book chapters on mood disorders, depression, and schizophrenia. He is listed in the Best Doctors in America and America's Top Doctors and received the 1997 Exemplary Psychiatrist Award of the National Alliance for the Mentally Ill.

We offer both print and online subscriptions. Our web site provides subscribers with 24-hour access to archives as well as current issues. In addition, Continuing Medical Education credit is available for reading BTP. You can earn up to 12.0 hours in category 1 credit by answering questions in the December issue about topics covered during the year.